Product Name :
iFSP1
Description:
iFSP1 is a potent, selective and glutathione-independent inhibitor of ferroptosis suppressor protein 1 (FSP1) (AIFM2) with an EC50 of 103 nM. iFSP1 selectively induces ferroptosis in GPX4-knockout cells which overexpressed FSP1. iFSP1 is able to sensitize a variety of human cancer cell lines to the ferroptosis inducer, such as (1S, 3R)-RSL3 (HY-100218A).
CAS:
150651-39-1
Molecular Weight:
323.35
Formula:
C20H13N5
Chemical Name:
13-amino-11-(4-methylphenyl)-1, 8-diazatricyclo[7.4.0.0, ]trideca-2, 4, 6, 8, 10, 12-hexaene-10, 12-dicarbonitrile
Smiles :
CC1C=CC(=CC=1)C1C(C#N)=C(N)N2C(=NC3=CC=CC=C23)C=1C#N
InChiKey:
FNESYDFRCQEEKA-UHFFFAOYSA-N
InChi :
InChI=1S/C20H13N5/c1-12-6-8-13(9-7-12)18-14(10-21)19(23)25-17-5-3-2-4-16(17)24-20(25)15(18)11-22/h2-9H,23H2,1H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.Insulin lispro manufacturer
Shelf Life:
≥360 days if stored properly.4-Hydroxynonenal Aldehyde Dehydrogenase (ALDH)
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:33359432
Additional information:
iFSP1 is a potent, selective and glutathione-independent inhibitor of ferroptosis suppressor protein 1 (FSP1) (AIFM2) with an EC50 of 103 nM. iFSP1 selectively induces ferroptosis in GPX4-knockout cells which overexpressed FSP1. iFSP1 is able to sensitize a variety of human cancer cell lines to the ferroptosis inducer, such as (1S, 3R)-RSL3 (HY-100218A).|Product information|CAS Number: 150651-39-1|Molecular Weight: 323.35|Formula: C20H13N5|Chemical Name: 13-amino-11-(4-methylphenyl)-1, 8-diazatricyclo[7.4.0.0, ]trideca-2, 4, 6, 8, 10, 12-hexaene-10, 12-dicarbonitrile|Smiles: CC1C=CC(=CC=1)C1C(C#N)=C(N)N2C(=NC3=CC=CC=C23)C=1C#N|InChiKey: FNESYDFRCQEEKA-UHFFFAOYSA-N|InChi: InChI=1S/C20H13N5/c1-12-6-8-13(9-7-12)18-14(10-21)19(23)25-17-5-3-2-4-16(17)24-20(25)15(18)11-22/h2-9H,23H2,1H3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 20 mg/mL (61.85 mM; Need ultrasonic)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥360 days if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|iFSP1 (0.001-1 μM; 24 hours) inhibits the Gpx4-knockout cell growth as a dose-dependent manner, but does not inhibit the wild type cell growth. Treatment with the ferroptosis inhibitor Lip-1 protects GPX4- knockout cells from iFSP1-induced ferroptosis[1]. iFSP1 (0.001-1 μM; 24 hours) is less efficient than genetic deletion of FSP1, whereas iFSP1 treatment in the FSP1-knockout background had no additive effect to RSL3-induced ferroptosis. iFSP1 (3 μM; 24 hours) treatment results in an obvious toxicity of RSL3 in a panel of genetically engineered (FSP1-knockout) human cancer cell lines. AIFM2: the flavoprotein apoptosis-inducing factor mitochondria-associated 2 is a previously unrecognized anti-ferroptotic gene. AIFM2, which is renamed ferroptosis suppressor protein 1 (FSP1)|References:|Doll S, et al. FSP1 is a glutathione-independent ferroptosis suppressor.Nature. 2019 Nov;575(7784):693-698.Products are for research use only. Not for human use.|